.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
This study evaluated whether intraoperative neuromonitoring (IONM) improves the extent of tumour resection while reducing postoperative neurological deficits in children undergoing supratentorial brain tumour surgery. The analysis included 41 studies involving 1,908 paediatric patients. Gross total resection was achieved in 76.9% of patients in the IONM group compared with 52.8% in the non-IONM group, while postoperative neurological deficits occurred in 15.1% and 23.1%, respectively. The benefits appeared particularly relevant in tumours involving eloquent cortical regions. The authors concluded that IONM may support safer and more extensive tumour resection; however, the included studies did not provide direct comparisons within the same cohorts, so a causal benefit cannot be established.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This study evaluated whether intraoperative neuromonitoring (IONM) improves the extent of tumour resection while reducing postoperative neurological deficits in children undergoing supratentorial brain tumour surgery. The analysis included 41 studies involving 1,908 paediatric patients. Gross total resection was achieved in 76.9% of patients in the IONM group compared with 52.8% in the non-IONM group, while postoperative neurological deficits occurred in 15.1% and 23.1%, respectively. The benefits appeared particularly relevant in tumours involving eloquent cortical regions. The authors concluded that IONM may support safer and more extensive tumour resection; however, the included studies did not provide direct comparisons within the same cohorts, so a causal benefit cannot be established.
Today
A recent preclinical study demonstrates that verapamil increases peak plasma concentrations of saxagliptin and enhances its blood glucose-lowering efficacy in both healthy and diabetic models, offering key pharmacological insights for clinicians managing comorbid diabetes and cardiovascular disease.
Today
Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today
Phase 3 clinical trial data demonstrate that plozasiran significantly reduces plasma triglycerides and sharply lowers acute pancreatitis incidence in patients with severe hypertriglyceridemia, offering a promising targeted siRNA therapy for high-risk lipid management.
Today
Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Yesterday
The randomized HOBIT-AF trial reveals that while structured weight loss after catheter ablation significantly improves cardiometabolic health in obese patients with paroxysmal atrial fibrillation, it does not reduce arrhythmia recurrence compared to standard care.
Today
